These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26248120)

  • 21. Current and future HCV therapy: do we still need other anti-HCV drugs?
    Petta S; Craxì A
    Liver Int; 2015 Jan; 35 Suppl 1():4-10. PubMed ID: 25529081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing treatment in HIV/HCV coinfection.
    Puoti M; Rossotti R; Travi G; Panzeri C; Morreale M; Chiari E; Cocca G; Orso M; Moioli MC
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S355-62. PubMed ID: 24091116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High rates of unprotected anal sex and use of generic direct-acting antivirals in a cohort of MSM with acute HCV infection.
    Girometti N; Devitt E; Phillips J; Nelson M; Whitlock G
    J Viral Hepat; 2019 Jun; 26(6):627-634. PubMed ID: 30661272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man.
    Franco S; Tural C; Nevot M; Moltó J; Rockstroh JK; Clotet B; Martinez MA
    Gastroenterology; 2014 Sep; 147(3):599-601.e1. PubMed ID: 24859204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV-HIV co-infected patients: no longer a 'special' population?
    Sulkowski MS
    Liver Int; 2016 Jan; 36 Suppl 1():43-6. PubMed ID: 26725896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.
    Piroth L; Paniez H; Taburet AM; Vincent C; Rosenthal E; Lacombe K; Billaud E; Rey D; Zucman D; Bailly F; Bronowicki JP; Simony M; Diallo A; Izopet J; Aboulker JP; Meyer L; Molina JM;
    Clin Infect Dis; 2015 Sep; 61(5):817-25. PubMed ID: 25977266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection.
    El-Sherif O; Khoo S; Solas C
    Curr Opin HIV AIDS; 2015 Sep; 10(5):348-54. PubMed ID: 26248122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
    Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.
    Klein MB; Rollet KC; Hull M; Cooper C; Walmsley S; Conway B; Pick N;
    Antivir Ther; 2013; 18(5):717-21. PubMed ID: 23211632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low rate of sustained virological response in an outbreak of acute hepatitis C in HIV-infected patients.
    Laguno M; Martínez-Rebollar M; Perez I; Costa J; Larrousse M; Calvo M; Loncá M; Muñoz A; González-Cordón A; Blanco JL; Martínez E; Gatell JM; Mallolas J
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1294-300. PubMed ID: 22428909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals.
    Cope R; Pickering A; Glowa T; Faulds S; Veldkamp P; Prasad R
    AIDS Patient Care STDS; 2015 Jul; 29(7):379-83. PubMed ID: 26066094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus: standard-of-care treatment.
    Pawlotsky JM
    Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide.
    Kouyos RD; Rauch A; Braun DL; Yang WL; Böni J; Yerly S; Klimkait T; Aubert V; Shah C; Kovari H; Calmy A; Cavassini M; Battegay M; Vernazza PL; Bernasconi E; Ledergerber B; Günthard HF;
    J Infect Dis; 2014 Nov; 210(10):1555-61. PubMed ID: 24943723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients.
    Del Bello D; Ita Nagy F; Hand J; Khedemi R; Lécluse-Barth J; Dieterich D; Piroth L
    Curr Opin HIV AIDS; 2015 Sep; 10(5):337-47. PubMed ID: 26248121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
    Zeremski M; Martinez AD; Talal AH
    Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
    [No Abstract]   [Full Text] [Related]  

  • 37. Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?
    Sacks-Davis R; Pedrana AE; Scott N; Doyle JS; Hellard ME
    Expert Rev Anti Infect Ther; 2018 May; 16(5):411-422. PubMed ID: 29722275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Virus Transmission Among Men Who Have Sex With Men in Amsterdam: External Introductions May Complicate Microelimination Efforts.
    Koopsen J; Parker E; Han AX; van de Laar T; Russell C; Hoornenborg E; Prins M; van der Valk M; Schinkel J
    Clin Infect Dis; 2021 Jun; 72(12):e1056-e1063. PubMed ID: 33289036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C following liver transplantation: current approach and future research opportunities.
    Cosar AM; Durand CM; Cameron AM; Gurakar A
    Curr Opin Infect Dis; 2016 Aug; 29(4):346-52. PubMed ID: 27191202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct-acting antiviral treatment of acute hepatitis C virus infections.
    Misra S; Dieterich DT; Saberi B; Kushner T
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):599-610. PubMed ID: 30067402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.